3 Multiple Myeloma Clinical Trials in Saint Augustine, FL (2026)

Q: How do I join a clinical trial in Saint Augustine?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Saint Augustine research site will contact you.

Recruiting Multiple Myeloma Studies in Saint Augustine

NCT07457918Recruiting

Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)

People who participated in either the COVE-2 or COVE-3 study for common warts, may be eligible to enroll into this Long Term Follow Up (LTFU) study COVE-4. The main question(s) to answer in this LTFU ...

Saint Augustine, FL600 participantsVerrica Pharmaceuticals Inc.

View Study Details

NCT06679101Recruiting

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

The purpose of this Phase 3 study is to evaluate if BRd prolongs progression free survival (PFS) and/or improves minimal residual disease (MRD) negative status compared with DRd in participants with T...

Saint Augustine, FL520 participantsGlaxoSmithKline

View Study Details

NCT07246590Recruiting

Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)

This is a Phase 3, double-blind, randomized, vehicle-controlled study (Study number VP-CW-301; referred to as COVE-2 \[Cantharidin and Occlusion in Verruca Epithelium\]) to evaluate the efficacy and s...

Saint Augustine, FL300 participantsVerrica Pharmaceuticals Inc.

View Study Details

About Multiple Myeloma Clinical Trials in Saint Augustine

Multiple myeloma is a cancer of plasma cells in the bone marrow that produce abnormal antibodies. It can cause bone damage, kidney problems, and immune deficiency. Treatments have advanced significantly with proteasome inhibitors, immunomodulatory drugs, and CAR-T cell therapy.

There are currently 3 multiple myeloma clinical trials recruiting participants in Saint Augustine, FL. These studies are seeking a combined 1,420 participants. Research is being sponsored by Verrica Pharmaceuticals Inc., GlaxoSmithKline. Clinical trial participation is free and participants receive study-related medical care at no cost.

Multiple Myeloma Clinical Trials in Saint Augustine — FAQ

Are there multiple myeloma clinical trials in Saint Augustine?

Yes, there are 3 multiple myeloma clinical trials currently recruiting in Saint Augustine, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Saint Augustine?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Saint Augustine research site will contact you about next steps.

Are clinical trials in Saint Augustine free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Saint Augustine studies also compensate for your time and travel.

What multiple myeloma treatments are being tested?

The 3 active trials in Saint Augustine are testing new therapies including novel drugs, biologics, and treatment approaches for multiple myeloma.

Data updated July 13, 2026 from ClinicalTrials.gov